Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Allocation / Balanced · John Hancock

Lifestyle Blend Moderate Portfolio Class R6 (JLMRX)

Ticker JLMRX · · Holdings as of May 31, 2026

Expense ratio
0.72%$72/yr per $10k
5-yr return
+4.1%annualized
1-yr return
+7.5%as of Dec 2024
Net assets
$508.1Mall share classes
Holdings
35

Bottom line

Is JLMRX a good fund? The bottom line

JLMRX is the Class R6 share class of Lifestyle Blend Moderate Portfolio, a managed allocation / balanced mutual fund from John Hancock.

It charges 0.72% — about $72 a year on every $10,000 invested, cheaper than 68% of allocation / balanced funds we track.

It returned +7.5% over one year, +4.1% a year over five years, +4.7% a year over ten (as of Dec 31, 2024, per its prospectus).

With $508 million in net assets and 35 holdings, its largest position is Vanguard Total Bond Market ETF Vanguard Total Bond Market (15.4%) and the top 10 make up 81.7% of the portfolio.

What to watch

  • 5-year return in the bottom quarter of its category
  • Concentrated: top 10 holdings are 81.7% of assets

Updated Nov 19, 2026

What JLMRX invests in

To seek a balance between a high level of current income and growth of capital, with a greater emphasis on income.

The fund operates as a fund of funds and, except as otherwise described below, normally invests approximately 60% of its assets in underlying funds that invest primarily in fixed-income securities and approximately 40% in underlying funds that invest primarily in equity securities. Underlying funds may be affiliated or unaffiliated and may include exchange-traded funds (ETFs). Variations in the target percentage allocation between underlying funds that invest primarily in equity securities and underlying funds that invest primarily in fixed-income securities are permitted up to 10%. Although variations beyond the 10% range are generally not permitted, the manager may determine, in light of market or economic conditions, that the normal percentage limitations should be exceeded to protect the fund or to achieve its goal. There is no limit on the range of maturities and credit quality of…

From the fund's prospectus (filed Dec 23, 2025).

JLMRX performance

Fund calendar-year total returns, 2015–2024 2015: −1.6%; 2016: +7.8%; 2017: +9.9%; 2018: −3.9%; 2019: +16.2%; 2020: +10.2%; 2021: +7.4%; 2022: −13.8%; 2023: +11.2%; 2024: +7.5% −2% 2015 +8% 2016 +10% 2017 −4% 2018 +16% 2019 +10% 2020 +7% 2021 −14% 2022 +11% 2023 +7% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
JLMRX+7.5%+4.1%+4.7%
Allocation / Balanced median+11.0%+5.7%+6.7%

Source: Fund prospectus, as of Dec 31, 2024

Full JLMRX performance history →

What JLMRX costs

On a $10,000 investment, JLMRX's 0.72% expense ratio costs about $72 a year. The prospectus estimates $894 in total costs over 10 years (assuming 5% annual returns). The median allocation / balanced fund charges 0.91%.

See the full JLMRX fee table →

JLMRX top 10 holdings

#Holding% of fund
1Vanguard Total Bond Market ETF Vanguard Total Bond Market BND US15.42%
2Hancock John Sovereign Bd Fd Mutual Fund JHBTUSD14.95%
3John Hancock Funds II Multimanager 2010 Lifetime Portfolio 47805T76513.66%
4Natixis 47805T77310.65%
5John Hancock Investors Trust JHEMDFN5.78%
6Fidelity Mid Cap Index Fund Fidelity Mid Cap Indx FSMDX4.84%
7John Hancock Investors Trust JHNHNYU4.20%
8John Hancock Global Senior Loa Jh Global Senior Loan ETF JHLN US4.17%
9Vanguard Short-term Corporate Vanguard S/t Corp Bond ETF VCSH US4.17%
10Vanguard FTSE Developed Markets ETF VEA US3.80%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 81.7% of the fund. See all top 25 holdings and asset mix →

Alternatives to JLMRX

More funds like JLMRX →

JLMRX FAQ

What is the expense ratio of JLMRX?
JLMRX's expense ratio is 0.72%, which works out to about $72 a year for every $10,000 invested. The prospectus estimates total costs of $894 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is JLMRX a good investment?
It depends on your goals, but the data points to: 5-year return in the bottom quarter of its category; concentrated: top 10 holdings are 81.7% of assets. This is general information, not personalized advice.
What does JLMRX hold?
JLMRX's largest holdings are Vanguard Total Bond Market ETF Vanguard Total Bond Market (15.4%), Hancock John Sovereign Bd Fd Mutual Fund (14.9%), John Hancock Funds II Multimanager 2010 Lifetime Portfolio (13.7%), Natixis (10.7%), John Hancock Investors Trust (5.8%). It holds 35 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is JLMRX's 5-year return?
JLMRX returned +4.1% a year over the five years ending Dec 31, 2024, and +4.7% a year over ten years. Past performance does not guarantee future results.
Who manages JLMRX?
JLMRX is offered by John Hancock through John Hancock Funds II.